AMP(lify) Your Knowledge About the AMP Final Rule

 In Blog, Pharmaceuticals, US

Following through on our commitment to the life science industry, Model N hosted a webinar on February 2, 2016 with John Shakow, Partner at King & Spalding, and Jesse Mendelsohn, Senior Director at Model N, that discussed the recently published AMP Final Rule. A timely topic, it was attended by 195 people representing 76 different life sciences companies.

John shared valuable insights on the final rule including topics such as:

  • Definition of “Retail Community Pharmacy” and “Not Generally Dispensed”
  • Territories included in the rebate program
  • Bundling arrangements
  • Line extensions
  • Authorized generics
  • Bona fide service fees
  • and much more!

Jesse shared Model N’s vision for helping its Government Pricing and Medicaid customers adapt to the new ruling as well as changes coming to Model N’s products via its Regulatory Update Program (RUP). The attendees asked many good questions regarding Model N’s upcoming product changes and the legal interpretation of some of the finer points of the rule.

Please join us at the Rainmaker 2016 conference in Scottsdale on February 22 and 24 where John and Jesse will host live sessions regarding the rule and other changes in the government pricing arena. Register here to learn more about the AMP Final Rule and network with industry leaders and peers.

Recent Posts

Start typing and press Enter to search